NEET
08/15/2026 (Sat) 04:13
No.1020600
del
08/15/2026 (Sat) 04:13
No.1020600
del
>>1020598
AI Slop says potentially for the other one.
>In Australia, Ozempic is TGA-approved for type 2 diabetes, not prediabetes. Its PBS subsidy is also for people who meet type 2 diabetes criteria. A doctor can sometimes consider medicines outside their approved indication, but if the main issue is prediabetes/weight, Wegovy is usually the semaglutide product that fits the approved indication better.
>Wegovy contains the same active drug, semaglutide, but is approved for chronic weight management in adults with either a BMI of 30 or above, or a BMI of 27–29.9 plus a weight-related health problem. Prediabetes was specifically included among the weight-related conditions in the Wegovy clinical trials described in the Australian product information.
AI Slop says potentially for the other one.
>In Australia, Ozempic is TGA-approved for type 2 diabetes, not prediabetes. Its PBS subsidy is also for people who meet type 2 diabetes criteria. A doctor can sometimes consider medicines outside their approved indication, but if the main issue is prediabetes/weight, Wegovy is usually the semaglutide product that fits the approved indication better.
>Wegovy contains the same active drug, semaglutide, but is approved for chronic weight management in adults with either a BMI of 30 or above, or a BMI of 27–29.9 plus a weight-related health problem. Prediabetes was specifically included among the weight-related conditions in the Wegovy clinical trials described in the Australian product information.